Core Viewpoint - The stock of Dirui Medical closed at 13.78 yuan, marking a 1.62% increase, with a rolling PE ratio of 104.96, the lowest in 39 days, and a total market capitalization of 3.758 billion yuan [1] Company Summary - Dirui Medical specializes in the research, production, marketing, and service of medical testing instruments and related test strips and reagents [1] - The company has a total of 213 patents, including 136 invention patents, and has obtained 96 software copyrights [1] - For Q1 2025, Dirui Medical reported revenue of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.68 million yuan, down 87.13%, with a gross profit margin of 42.78% [1] Industry Summary - The average PE ratio for the medical device industry is 50.80, with a median of 36.71, placing Dirui Medical at 107th in the industry ranking [2] - The static PE ratio for Dirui Medical is 26.48, and the price-to-book ratio is 1.82 [2] - The total market capitalization of Dirui Medical is 3.758 billion yuan, compared to the industry average market capitalization of 10.836 billion yuan [2]
迪瑞医疗收盘上涨1.62%,滚动市盈率104.96倍,总市值37.58亿元